Next Article in Journal
Lyso-IP: Uncovering Pathogenic Mechanisms of Lysosomal Dysfunction
Next Article in Special Issue
Meroterpenoids Possibly Produced by a Bacterial Endosymbiont of the Tropical Basidiomycete Echinochaete brachypora
Previous Article in Journal
Roles of mTOR in the Regulation of Pancreatic β-Cell Mass and Insulin Secretion
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 12
Issue 5
10.3390/biom12050615
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Essential Oils of Duguetia Species A. St. Hill (Annonaceae): Chemical Diversity and Pharmacological Potential

by
Albert C. dos Santos
1,
Mateus L. Nogueira
2,
Felipe P. de Oliveira
2,
Emmanoel V. Costa
1,* and
Daniel P. Bezerra
2,*
1
Department of Chemistry, Federal University of Amazonas (UFAM), Manaus 69080-900, AM, Brazil
2
Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, BA, Brazil
*
Authors to whom correspondence should be addressed.
Biomolecules 2022, 12(5), 615; https://doi.org/10.3390/biom12050615
Submission received: 7 March 2022 / Revised: 13 April 2022 / Accepted: 18 April 2022 / Published: 21 April 2022
(This article belongs to the Special Issue Natural Chemodiversity & Bioprospecting for Drug Discovery)
Browse Figures
Versions Notes

Abstract

:
Duguetia A. St. Hill (Annonaceae) is recognized as one of the major genera with approximately 100 species, 67 of which are found in Brazil (29 of those are endemic). They are arboreal species with edible fruits known as “pindaíba”, “pindaíva” “pinha”, and “envira” in Brazil. Many Duguetia species, in particular, have been used in traditional medicine to treat renal colic, stomachache, rheumatism, cough, toothache, muscle pain, fever, gastrointestinal pain, and breathing difficulties. In this study, we reviewed the chemical constituents and pharmacological properties of essential oils (EOs) from Duguetia species. A total of 12 species were found, along with their EO chemical constituents and bioactivities. Bicyclogermacrene, humulene epoxide II, spathulenol, germacrene D, caryophyllene oxide, viridiflorene, α-pinene, β-caryophyllene, and β-pinene were the main chemical constituents reported. The pharmacological effects of Duguetia species EOs included anti-inflammatory, antinociceptive, antibacterial, antifungal, antioxidant, anti-trypanosoma, cytotoxic and antitumor properties. This information adds to our understanding of the potential of the EOs of Duguetia species.

1. Introduction

The Annonaceae family is one of the largest in the Magnolalies order, with approximately 112 genera and 2440 species [1]. There are 32 genera and 392 species reported in Brazil, with three genera and 162 species being endemic [2]. The Amazon biome contains the greatest diversity of Annonaceae, with 27 genera and 280 species [2,3]. The main feature of this family is the availability of edible fruits, particularly those of the Annona and Duguetia species: Annona squamosa L. (sugar apple); Annona mucosa Jacq. (wild sweetsop); Annona muricata L. (soursop); Duguetia lanceolata A. St.-Hill (pindaba); and Duguetia furfuracea (cherry sugarapple) [1,2,3,4,5].
Duguetia A. St. Hill., along with Guatteria and Annona, is one of the largest genera in the Annonaceae family. This genus is found throughout the neotropics, including South America (from Nicaragua to Brazil) and the African Atlantic coast. Its trees or shrubs have flowers in the upper part of the trunk or long branches close to the ground from the trunk’s base. Leaves are adistichous with a midrib impressed on the upper side; flowers range from white to yellow. Fruits are pseudosyncarpous (carpels strongly coherent, but not or only partly connate), composed of 5 to over 500 carpels, with seeds (dark brown, obovoid, smooth, not arillate) embedded in a fleshy pulp [4,5].
Currently, the Duguetia genus contains approximately 100 species, 67 of which are found in Brazil and 29 of which are considered endemic [6,7,8,9]. Several Duguetia species have edible fruits with high economic value in Brazil, which are popularly known as “pindaíba”, “pindaíva”, “pinha”, and “envira” [4,5]. In terms of phytogeography distribution, 45 species are mostly found in the Amazon biome, while 17 are found in the Atlantic Forest [8].
Many species in the Duguetia genus are widely used to treat diseases such as renal colic, stomachache, rheumatism, cough, toothache, muscle pain, fever, gastrointestinal pain, and breathing difficulties [6,10,11,12,13,14,15,16,17]. The species used in traditional medicine are summarized in Table 1. On the other hand, while many ethnopharmacological uses for Duguetia species have been reported, only a few studies involving the chemical and therapeutic properties of this genus’ plants have been found.
According to Perez and Cassels [6], the chemical composition of this genus includes secondary metabolites, particularly alkaloids, found in various parts of Duguetia species. Furthermore, numerous studies have revealed the presence of steroids, flavonoids, aromatic compounds and terpenes. However, knowledge of the chemical composition and biological activities of this genus’ essential oils (EOs) is limited.
To guide future research, we discuss the chemical constituents and pharmacological properties of EOs of Duguetia species in this review. Google Scholar, PubMed, Science Direct, SciFinder, Scopus and Web of Science were used for searches. The following keywords were used: “Annonaceae”; Duguetia”; “essential oil”; “volatile constituents”; “volatile compounds”; and “biological activity”. A total of 82 articles were identified and reviewed, with those that included chemical constituents and biological activities of EOs being chosen and discussed.

2. Chemical Constituents of Duguetia Species EOs

EOs are natural, complex and volatile mixtures that can contain from 20 to 60 components in varying concentrations, with two or three main components having relatively high concentrations (20–70%) when compared to others that are present in small amounts, as well as having a strong odor and being composed of secondary metabolites [18,19]. The extraction of EOs is achieved through hydrodistillation or dragging of plant material with water vapor, and they are derived from various parts of aromatic plants (flowers, leaves, stem, branches, bark, wood, seeds and fruits), which are generally found in temperate- to hot-climate countries. They are well known for being liquid, clear, volatile, rarely colored, and soluble in lipids and organic solvents with densities less than water [20]. Furthermore, the chemical composition and biological activities of EOs can vary depending on the season, geographic area, climate, soil conditions, water stress, nutrition, isolation, or other abiotic factors [21,22].
Table 2 lists the main chemical constituents of EOs of Duguetia species. In total, the chemical composition of 56 constituents found in EOs from 12 species of this genus has been reported. These were D. asterotricha (Diels) R. E. Fries, D. eximia Diels, D. flagellaris Huber, D. furfuracea (A. St.-Hil.) Benth. & Hook. f., D. gardneriana Mart., D. glabriuscula (R. E. Fries) R. E. Fries, D. lanceolate A.St.-Hil., D. moricandiana Mart., D. pycnastera Sandwith, D. quitarensis Benth., D. riparia Huber, and D. trunciflora Maas. Figure 1 shows the structures of the major compounds identified in the EOs of these species.
Terpenes were the most identified among the main constituents that have been reported. Monoterpenes (11 components), hydrocarbon sesquiterpenes (21 components), oxygenated sesquiterpenes (16 components), and other groups (eight components), including alcohol and phenylpropanoid, were also reported. The terpenes with the most records were spathulenol and germacrene D (six species), α-pinene and β-caryophyllene (five species), caryophyllene oxide (four species) and, finally, bicyclogermacrene, humulene epoxide II, viridiflorene, β-phellandrene and β-pinene (three species). When comparing the constituents of EOs of the Duguetia genus and the Annonaceae family, some are highlighted among the genera of this family (Annona, Anaxagorea, Fusae, Xylopia, Guatteria, Hexalobus, and Pachypodanthium) as chemophenetic markers [37], namely bicyclogermacrene, spathulenol, germacrene D, caryophyllene oxide, α-pinene, and β-caryophyllene [38,39,40].
Spathulenol is the main component identified in EOs from the stem and leaves of D. flagellaris [24], D. pycnastera [24] and D. riparia [24], as well as in EOs from the leaves of D. furfuracea [27] and the branches of D. flagellaris [25]. This same constituent is found in EOs extracted from the stem and leaves of D. eximia [24], D. furfuracea [26,29] and D. trunciflora [24].
Valter et al. [29] identified bicyclogermacrene as the major constituent in the EOs from the leaves of D. furfuracea, whereas it was only a minor component in EOs from the stem of D. furfuracea [17,26,28], D. pycnastera and D. trunciflora [24], and in EOs from the leaves of D. furfuracea [27,29], D. pycnastera and D. trunciflora [24].
Germacrene D has been identified as a major component in EOs extracted from the leaves of D. gardneriana and D. moricandiana [30], as well as the bark and stem of D. flagellaris [24,25]. However, it was discovered as a minor constituent in the EOs from the leaves of D. furfuracea [29], D. gardneriana [31] and D. pycnastera [24], as well as the EOs from the stem of D. pycnastera [24] and aerial parts of D. quitarensis [36].
In D. trunciflora, α-pinene was found to be the most abundant constituent in stem and leaf EO samples [24]. On the other hand, it was not considered the major compound in EOs from the leaves of D. gardneriana [30], D. moricandiana [30] and D. riparia [24]. Although α-pinene was found in the EOs extracted from the flowers of D. asterotricha [23] and the stem of D. riparia [24], it was in a lower proportion. The 2,4,5-trimethoxystyrene identified in D. furfuracea [26] was described as the main component in the EO from the stem; however, it was present in lower concentrations in the EOs from the leaves of D. lanceolata [34] and the stem of D. furfuracea [17,27,28].
Allo-aromadendrene is the main constituent in the EO from the leaves of D. gabriuscula, as reported by Siqueira et al. [32]; however, it was found as a minor constituent in the EO samples from the stem and leaves of D. pycnastera [24]. Sabinene is the component with the highest percentage in EO extracted from D. furfuracea leaves [29]. β-Elemene is the most prevalent constituent in EO samples from bark and branches of D. lanceolata [33,35], but it is considered a minor constituent in the EO from the bark of D. flagellaris [24].
β-Phellandrene was found in high concentrations in the EOs extracted from the leaves of D. furfuracea [29] and the bark of D. trunciflora [24]. Similarly, α-gurjunene was identified as a major constituent in EO extracted from the stem of D. furfuracea [27]. This component has been found in lower concentrations in other studies of EO samples from the same species’ stem [17,28].
α-Asarone was found as a major constituent in EO from the stem of D. furfuracea [17], whereas no similar results were found in other studies of stem EO samples from the same species [26,27]. According to Maia et al. [24], α-eudesmol was the main component in EO samples from the leaves and stem of D. eximia, whereas β-bisabolene was the main compound identified in the EOs from the leaves of D. gardneriana [31] and D. lanceolata [34]. Terpinen-4-ol, limonene, 4-heptanol and (E)-asarone were found in the highest concentrations in the EOs extracted from D. furfuracea leaves [29], D. asterotricha flowers [23], D. quitarensis aerial parts [36] and D. furfuracea stem [28], respectively.
Caryophyllene oxide was found in the EOs of D. flagellaris bark [24], D. furfuracea leaves [29], D. lanceolata bark and branches [33,35], and D. riparia leaves and stem [24]. Humulene epoxide II was found in the leaves and stem EOs of D. flagellaris and D. trunciflora [24]. This component can also be found in EOs derived from the bark of D. flagellaris [24] and D. lanceolata [33].
Cyperene was identified as a chemical component in EOs extracted from the stem of D. flagellaris [25] and D. furfuracea [17,27,28], and D. flagellaris bark [24]. Whereas Almeida et al. [30] discovered β-pinene in the EOs extracted from the leaves of D. gardneriana and D. moricandiana. This last constituent can also be found in EOs derived of D. trunciflora leaves and stem [24].
β-caryophyllene and its synonyms trans-caryophyllene and (E)-caryophyllene have been reported in EOs of D. furfuracea leaves and stem [27,28,29], D. gardneriana and D. moricandiana leaves [30], D. lanceolata branches [35], and D. quitarensis aerial parts [36]. The presence of α-muurolol in the EOs from the bark, branches and stem of D. flagellaris has been reported [24,25]. Viridiflorene was found in EOs from the leaves of D. gardneriana and D. moricandiana [30], whereas Siqueira et al. [32] found it in EO from the leaves of D. gabriuscula.
Bulnesol and guaiol have been identified in EOs from the bark, leaves and stem of D. trunciflora [24]. p-Cymene was found as a minor constituent in EOs of D. asterotricha flowers [23] and D. furfuracea leaves [29], while δ-cadinene was found in EOs of D. flagellaris bark [24] and D. lanceolata branches [35]. Siqueira et al. [32] found (–)-ledol, (+)-spathulenol and farnesyl acetate in D. gabriuscula leaf EO.
β-Selinene was detected in EOs extracted from the bark and branches of D. lanceolata [33,35]. Elemol was identified in EOs extracted from the leaves and stem of D. pycnastera [24]. Globulol was discovered in EOs extracted from the leaves and stem of D. trunciflora [24]. Viridiflorol was found in EOs extracted from the leaves of D. furfuracea [27] and D. gabriuscula [29].
Some specific constituents are found in EOs from only a few species of the Duguetia genus, including: α-muurolene in the D. flagellaris bark EO [24]; epi-globulol in D. furfuracea stem EO [26]; and myrcene and α-phellandrene in D. furfuracea leaf EO [29].
A similar report has been made for D. lanceolata, in which the constituents trans-muurola-4(14),5-diene and 3,4,5-trimethoxystyrene are present in the EO from the leaves [34], whereas in the branch EO, cadina-1,4-dien-3-ol, β-eudesmol and δ-elemene are found [35]. Bay et al. [36] identified α-copaene and α-thujene as components of EO from the aerial parts of D. quitarensis. Maia et al. [24] discovered (Z)-β-farnesene, 7-epi-sesquithujene and α-cadinol in D. trunciflora bark EO. Allo-aromadendra-14β-al was discovered in the EO of D. gabriuscula leaves [32].
Trans-m-mentha-4,8-diene was identified in EOs extracted from the stem of D. furfuracea [27], elemicin in the leaves of D. gardneriana [31], δ-cadinene in the leaves of D. furfuracea [29], and β-sinensal and khusinol in the bark of D. lanceolata [33].

3. Pharmacological Properties of Duguetia Species EO

Natural products’ medicinal capabilities have historically been recognized in the most diverse cultures, allowing for widespread use in traditional folk medicine [41]. These findings have piqued the interest of the scientific community, which has been looking for novel drugs in medicinal plants for decades. As a result, new molecules with biological activities are being discovered, investigated, and converted for clinical use at an increasing rate [42].
In this study, we discovered that the most commonly reported actions of Duguetia species EOs are anti-inflammatory, antinociceptive, antimicrobial, antioxidant and cytotoxic activities. The pharmacological properties of Duguetia species EOs are summarizes in Table 3.

3.1. Anti-Inflammatory Activity

In the carrageenan-induced edema assay in the paws of Wistar rats, the anti-inflammatory activity of D. lanceolata bark EO was demonstrated [43]. The edema volume was significantly reduced when tested at doses of 50, 100 and 200 mg/kg, corresponding to reductions of 20.83%, 36.46% and 48.96%, respectively. Following that, D. lanceolata branch EO was tested in carrageenan-induced paw edema and pleurisy in rats as well as in mouse models of acute ear inflammation caused by croton oil and arachidonic acid [35]. In this case, EO (200 mg/kg), which contains the sesquiterpenes β-elemene (8.3%), caryophyllene oxide (7.7%) and β-eudesmol (7.2%) as main components, reduced paw edema by 44.1% while also significantly reducing carrageenan-induced exudate volume (50%) and the number of leukocytes (32.2%) in the pleurisy of the animals. In a dose-dependent manner, EO also significantly reduced the ear edema induced by arachidonic acid and croton oil.
Similarly, EO from the stem of D. furfuracea, with major components (E)-asarone (21.9%) and bicyclogermacrene (16.7%), was evaluated in Swiss mice [28]. Lipopolysaccharide (LPS)-induced paw edema was inhibited by 10 mg/kg oral treatment with values greater than 86%. With the same dose, EO reduced TNF-α production and polymorphonuclear-cell recruitment, and increased the expression of inducible nitric-oxide synthase (iNOS) in the paw tissue. All of these effects were amplified by a phenylpropanoid-enriched fraction from D. furfuracea EO, with the main constituents being α-asarone (36.4%) and 2,4,5-trimethoxystyrene (27.8%) [17]. In this study, EO at doses of 3 and 10 mg/kg inhibited paw edema by 90.91% and 92.42%, respectively, 2 h after LPS injection. After 4 h, a significant reduction effect was also observed with percentages of 77.78% (3 mg/kg) and 81.48% (10 mg/kg).

3.2. Antinociceptive Activity

The antinociceptive properties of EO derived from D. lanceolate and D. furfuracea have been studied. Sousa et al. [44] demonstrated that D. lanceolata bark EO was effective in the acetic-acid-induced abdominal-contraction assay and in the reduction in time of paw licking induced by formalin, attributing the positive results to the probable action of the EO components on the central and peripheral nervous systems. In the acetic-acid-induced writhing test, an effective dose of 50% (ED50) of 21.79 mg/kg was found, with a significant antinociceptive effect ranging from the dose of 10 mg/kg to total inhibition of writhing at 200 mg/kg. Paw-licking time was also reduced in a dose-dependent manner, with an ED50 of 5.27 mg/kg in the first phase (neurogenic phase) and 1.43 mg/kg in the second phase (inflammatory phase) [43].
D. lanceolata branch EO was also evaluated. After administration of EO at 100 and 200 mg/kg, there was a significant inhibition of acetic-acid-induced abdominal contractions. EO reduced paw-licking time in the neurogenic and inflammatory phases at doses of 50, 100 and 200 mg/kg. After 60 and 90 min of treatment with D. lanceolata EO, the animals’ response time in the hot-plate assay significantly increased, with the antinociceptive capacity partially maintained even in the presence of an opioid antagonist. Finally, in the tail-immersion assay, treatment allowed for a significant increase in the duration of pain latency [35].
The antinociceptive effects of EO extracted from the stem of D. furfuracea were also studied at doses of 10 and 30 mg/kg [28]. Paw-licking time was significantly reduced in the neurogenic and inflammatory phases after treatment with both doses, with the highest dose inhibiting formalin-induced nociception by 45.62% and 34.17%, respectively. The opioid antagonist naloxone (5 mg/kg) quickly reversed this effect in both the primary and secondary phases. In the LPS-induced thermal-hyperalgesia model, EO administration increased reaction time, allowing for a longer-lasting antinociceptive response (greater than 6 h after LPS-induced nociception) than morphine administration (7.5 mg/kg). Its antinociceptive activity may be mediated by adenosinergic and opioidergic pathways, but the rota-rod test revealed no changes in mouse motor coordination after treatments with 3, 10 and 30 mg/kg of the EO [28].
Similarly, Saldanha et al. [17] demonstrated the antinociceptive capacity of the phenylpropanoid-enriched fraction of D. furfuracea EO. For doses of 30 mg/kg, formalin-induced nociception was inhibited in both phases, with inhibition indices of 44.06% in paw-licking time in the first phase and 39.84% in the second. The reaction time to the LPS-induced thermal-hyperalgesia model increased. These effects were mediated by adenosinergic- and opioidergic-receptor activation, but without causing losses in the coordinative motor capacity of the tested animals [17].

3.3. Antibacterial and Antifungal Activities

The antimicrobial properties of EO extracted from the leaves of D. gardneriana and D. moricandiana were tested using the standard gel-diffusion method against a panel of fungal and bacterial strains. The results showed that the EO had a low inhibitory capacity against the tested microorganisms. Total EO of D. gardneriana (100% concentration), with the main components germacrene D (28.1%), viridiflorene (24.0%) and β-pinene (12.6%), demonstrated action against Staphylococcus aureus and Candida guilliermondii. The total EO of D. moricandiana, which contained the main constituents germacrene D (44.3%), α-pinene (13.0%), and viridiflorene (9.3%), was only effective against Staphylococcus aureus and Candida albicans. The average diameter of the halos was 12 mm in all cases [30].
The chemical composition and biological activities of EO extracted from the bark of D. lanceolata were found to be dependent on the extraction time [33]. Its main constituents were β-elemene (12.7 and 14.9%), caryophyllene oxide (12.4 and 10.7%) and β-selinene (8.4 and 10.4%). The use of EO in concentrations of 5, 10 and 25 mg inhibited the growth zone of Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli and Candida albicans. The measurement of minimum inhibitory concentrations (MIC), which ranged from 20 to 125 μg/mL among microorganisms, confirmed this finding.
Bay et al. [36] investigated the EO from aerial parts of D. quitarensis. When tested using the microdilution-plate method, the EO, which was primarily composed of 4-heptanol (33.8%), α-thujene (18.4%) and (E)-caryophyllene (14.4%), demonstrated high antibacterial activity against Streptococcus mutans and Streptococcus pyogenes, with an MIC of 37.5 μg/mL against both gram-positive microorganisms.

3.4. Trypanocidal Activity

The trypanocidal activity of EO derived from the aerial parts of D. quitarensis Benth against T. cruzi trypomastigote and amastigote forms has been reported. The inhibitory concentration of 50% (IC50) for the EO was calculated to be 0.26 ± 0.06 μg/mL, which is approximately four times lower than the IC50 for benznidazole. However, when compared to the IC50 of EO in L929 cells, the selectivity index was found to be low (2.1 fold) [36].

3.5. Antioxidant Activity

Oxidative damage has been linked to the development and maintenance of inflammation, as well as the progression of many diseases. As a result, the antioxidant capacity of plants is being extensively researched. Sousa et al. [35] discovered antioxidant activity in D. lanceolata branch EO. The EO concentration required to scavenge 50% (effective concentration of 50%: EC50) of DPPH (2,2-diphenyl-1-picrylhydrazyl) free radicals was 159.4 ± 1.2 μg/mL, which was lower than the Fe3+ reducing power (187.8 ± 0.6 μg/ mL). The β-carotene/linoleic-acid bleaching assay also demonstrated this EO’s ability to inhibit lipid peroxidation by 41.5 ± 2.4%.

3.6. Cytotoxic and Antitumor Activity

Cytotoxicity studies are an important part of the drug-development process because they quickly provide vital information that serves as the initial platform in the search for new therapies for diseases such as cancer [45,46]. Despite being common among Annonaceae species, few studies have looked into the cytotoxic capacity of Duguetia species EO or their main components [47].
Matos et al. [44] found that (+)-allo-aromadendran-10,14β-diol, an aromadendrene-type sesquiterpene derived from the D. glabriuscula leaves EO, had a significant cytotoxic effect on human larynx carcinoma (Hep2) cells, with an IC50 value of 11.6 ± 2.3 μg/mL. The cytotoxic and antitumor potential of the EO of D. gardneriana leaves, with main components β-bisabolene (80.99%), elemicin (8.04%), germacrene D (4.15%), and cyperene (2.82%), was demonstrated against B16-F10 (16.89 µg/mL), HepG2 (19.16 µg/mL), HL-60 (13.08 µg/mL) and K562 (19.33 µg/mL) cancer cell lines [31]. Tumor-growth-inhibition rates of 5.37 and 37.52% were observed in C57BL/6 mice inoculated with B16-F10 cells after daily treatment with EO at 40 and 80 mg/kg/day, respectively [31].
The EO obtained from dry and fresh leaves of D. glabriuscula, with predominance of aromadendrene-type sesquiterpenes in its constitution (61.3% and 59.0%, from fresh and dried leaves, respectively), demonstrated toxic activity against Artemia salina in brine shrimp lethality bioassay (lethal concentration of 50%: LC50 = 1.6 mg/mL) [32]. Silva et al. [26] found that EO derived from the stem of D. furfuracea was active against A. salina, with an LC50 value of 2.6 μg/mL. The EO derived from stem of D. furfuracea (α-gurjunene: 22.2%; 2,4,5-trimethoxystyrene: 19.7%; cyperene: 16.0%) was toxic activity against A. salina, with an LC50 value of 715.2 mg/cm3 [27].
The toxicity of EO obtained from the bark of D. lanceolata, with β-elemene (12.7 and 14.9%), caryophyllene oxide (12.4 and 10.7%) and β-selinene (8.4 and 10.4%) as major components, was demonstrated by a brine-shrimp (A. salina)-lethality bioassay, with LC50 values of 49.0 μg/mL and 60.7 μg/mL, corresponding to different time of extraction [33].
Finally, Sousa et al. [35] evaluated the acute toxicity of D. lanceolata branch EO in Swiss albino mice. After oral administration of up to 3 g/kg of EO, the 50% lethal dose was calculated and determined to be 2.9 g/kg for 48 h. This assessment enabled the safe estimation of pharmacological doses for future experiments.

3.7. Other Activities

Ribeiro et al. [34] demonstrated the antiaflatoxigenic and insecticidal properties of EO extracted of D. lanceolata leaves. The EO, which is primarily composed of β-bisabolene (56.2%) and 2,4,5-trimethoxystyrene (19.1%), inhibited radial growth of Aspergillus flavus CCT7638 (Ascomycota) and the production of aflatoxin B1 from this isolate in a concentration-dependent manner.
Finally, the insecticidal activity was demonstrated using a residual-contact bioassay, which revealed a promising lethal effect on the adult forms of Sitophilus zeamais and Zabrotes subfasciatus (LC50 = 457 mg/kg and 442 mg/kg, respectively). The EO also significantly reduced the number of individuals emerging from the treated samples (EC50 = 480 mg/kg in adult S. zeamais; EC50 = 119 mg/kg in F1 progeny Z. subfasciatus), as well as the number of Z. subfasciatus eggs per treated sample (EC50 = 118 mg/kg) [34].

4. Conclusions

In recent years, studies on the genus Duguetia have focused on alkaloid constituents, resulting in few studies on EOs. As a result, this study discussed the chemical composition and pharmacological activities of the EOs of Duguetia species, demonstrating that this genus is a promising source of biologically active compounds. In this study, we discovered 56 chemical constituents found in 37 EOs of Duguetia species. The majority of the reported components are terpenes, specifically, monoterpenes, hydrocarbon and oxygenated sesquiterpenes. Bicyclogermacrene, humulene epoxide II, spathulenol, germacrene D, caryophyllene oxide, viridiflorene, α-pinene, β-caryophyllene and β-pinene are among these. The EOs of Duguetia species have been shown to have anti-inflammatory, antinociceptive, antibacterial, antifungal, antioxidant, anti-trypanosoma, cytotoxic, antitumor, antiaflatoxigenic and insecticidal properties. Figure 2 summarizes these findings. Further research into the chemical composition and pharmacological properties of the EOs of Duguetia species should be carried out in other species in order to assess their promising potential. In terms of future perspectives, mechanisms of action and toxicology studies should also be carried out in order to conduct clinical trials with these EOs.

Author Contributions

A.C.d.S. discussed about chemical constituents of Duguetia species EO; M.L.N. and F.P.d.O. discussed about pharmacological properties of Duguetia species EO; E.V.C. and D.P.B. planned this review and reviewed the whole text. All authors have read and agreed to the published version of the manuscript.

Funding

M.L.N. and F.P.d.O. receive personal scholarship from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Brazil). E.V.C. and D.P.B. receive personal scholarship from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors have declared that there are no conflict of interest.

Abbreviations

DPPH2,2-diphenyl-1-picrylhydrazyl
EC50effective concentration of 50%
ED50effective dose of 50%
EOsessential oils
IC50inhibitory concentration of 50%
LC50lethal concentration of 50%
LPSlipopolysaccharides
MICminimum inhibitory concentration

References

  1. Couvreur, T.L.P.; Pirie, M.D.; Chatrou, L.W.; Saunders, R.M.K.; SU, Y.C.F.; Richardson, J.E.; Erkens, R.H.J. Early evolutionary history of the flowering plant family Annonaceae: Steady diversification and boreotropical geodispersal. J. Biogeogr. 2011, 38, 664–680. [Google Scholar] [CrossRef]
  2. Lobão, A.Q.; Lopes, J.C.; Erkens, R.H.J.; Mendes-Silva, I.; Pontes Pires, A.F.; Silva, L.V.; Oliveira, M.L.B.; Johnson, D.; Mello-Silva, R. (In Memoriam). Annonaceae in Flora do Brasil 2020. Rio de Janeiro: Jardim Botânico do Rio de Janeiro. 2020. Available online: http://floradobrasil.jbrj.gov.br/reflora/floradobrasil/FB110219 (accessed on 11 August 2021).
  3. Maas, P.J.M.; Rainer, H.; Lobão, A.Q. Annonaceae in Lista de Espécies da Flora do Brasil. Rio de Janeiro: Jardim Botânico do Rio de Janeiro. 2013. Available online: http://floradobrasil.jbrj.gov.br/jabot/floradobrasil/FB110219 (accessed on 12 August 2021).
  4. Maas, P.J.M.; Maas, H.; Miralha, J.M.S. Flora da Reserva Ducke, Amazonas, Brasil: Annonaceae. Rodriguesia 2007, 58, 617–662. [Google Scholar] [CrossRef] [Green Version]
  5. Lopes, J.C.; Silva, R.M. Annonaceae da Reserva Natural Vale, Linhares, Espírito Santo. Rodriguesia 2014, 65, 599–635. [Google Scholar] [CrossRef]
  6. Perez, E.G.; Cassels, B.K. Alkaloids from the Genus Duguetia. Alkaloids Chem. Biol. 2010, 68, 83–156. [Google Scholar]
  7. Gonçalves, G.L.P.; Domingues, V.C.; Ribeiro, L.P.; Fernandes, J.B.; Fernandes, M.F.G.; Forim, M.R.; Vendramim, J.D. Compounds from Duguetia lanceolata St.-Hil. (Annonaceae) bioactive against Zabrotes subfasciatus (Boheman) (Coleoptera: Chrysomelidae: Bruchinae). Ind. Crops Prod. 2017, 97, 360–367. [Google Scholar] [CrossRef]
  8. Lobão, A.Q. Duguetia in Flora do Brasil 2020. Rio de Janeiro: Jardim Botânico do Rio de Janeiro. 2020. Available online: http://floradobrasil.jbrj.gov.br/reflora/floradobrasil/FB110296 (accessed on 15 August 2021).
  9. Nardelli, V.B.; Souza, C.A.S.; Chaar, J.S.; Koolen, H.H.F.; Silva, F.M.A.; Costa, E.V. Isoquinoline-derived alkaloids and one terpene lactone from the leaves of Duguetia pycnastera (Annonaceae). Biochem. Syst. Ecol. 2021, 94, 23–26. [Google Scholar] [CrossRef]
  10. Bevalot, F.; Leboeuf, M.; Bouquet, A.; Cavé, A. Dosage de I’allantoine. Ann. Pharm. Fr. 1977, 35, 65. [Google Scholar]
  11. Silberbauer-Gottsberger, I. O cerrado como potencial de plantas medicinais e tóxicas. Oréades 1981, 8, 15–30. [Google Scholar]
  12. Navarro, V.R.; Sette, I.M.F.; Da Cunha, E.V.L.; Silva, M.S.; Barbosa-Fiho, J.M.; Maia, J.G.S. Alcaloides de Duguetia flagellaris Huber (Annonaceae). Rev. Bras. Pl. Med. 2001, 3, 23–29. [Google Scholar]
  13. Pott, A.; Pott, V.J. Plantas do Pantanal; EMBRAPA: Corumba, Brazil, 1994. [Google Scholar]
  14. Defilipps, R.A.; Maina, S.L.; Crepin, J. Medicinal Plants of the Guianas (Guyana, Surinam, French Guiana); Department of Botany, National Museum of Natural History, Smithsonian Institution: Washington, DC, USA, 2004; pp. 20013–27012. [Google Scholar]
  15. Almeida, J.R.G.S.; Oliveira, M.R.; Guimarães, A.L.; Oliveira, A.P.; Ribeiro, L.A.A.; Lúcio, A.S.S.C.; Quintans, L.J., Jr. Phenolic quantification and antioxidant activity of Anaxagorea dolichocarpa and Duguetia chrysocarpa (Annonaceae). Int. J. Pharma Bio Sci. 2011, 2, 367–374. [Google Scholar]
  16. Almeida, J.R.G.S.; Araújo, E.C.C.; Ribeiro, L.A.A.; De Lima, J.T.; Nunes, X.P.; Lúcio, A.S.S.C.; Agra, M.F.; Filho, J.M.B. Antinociceptive activity of ethanol extract from Duguetia chrysocarpa Maas (Annonaceae). Sci. World J. 2012, 2012, 859210. [Google Scholar] [CrossRef] [Green Version]
  17. Saldanha, A.A.; Vieira, L.; Maia, D.S.S.; Oliveira, F.M.; Ribeiro, R.I.M.A.; Thomé, R.G.; Santos, H.B.; Lopes, D.O.; Carollo, C.A.; Silva, D.B.; et al. Anti-inflammatory and antinociceptive activities of a phenylpropanoid-enriched fraction of Duguetia furfuracea. Inflammopharmacology 2021, 29, 409–422. [Google Scholar] [CrossRef]
  18. Dudareva, N.; Negre, F.; Nagegowda, D.A.; Orlova, I. Plant volatiles: Recent advances and future perspectives. Crit. Rev. Plant Sci. 2006, 25, 417–440. [Google Scholar] [CrossRef]
  19. Maffei, M.E.; Gertsch, J.; Appendino, G. Plant volatiles: Production, function and pharmacology. Nat. Prod. Rep. 2011, 28, 1359–1380. [Google Scholar] [CrossRef]
  20. Bakkali, F.; Averbeck, S.; Averbeck, D.; Idaomar, M. Biological effects of essential oils—A review. Food Chem. Toxicol. 2008, 46, 446–475. [Google Scholar] [CrossRef]
  21. Carvalho-Filho, J.L.S.; Blank, A.F.; Alves, P.B.; Ehlert, P.A.D.; Melo, A.S.; Cavalcanti, S.C.H.; Arrigoni-Blank, M.F.; Silva-Mann, R. Influence of the harvesting time, temperature and drying period on basil (Ocimum basilicum L.) essential oil. Rev. Bras. Farmacogn. 2006, 16, 24–30. [Google Scholar] [CrossRef]
  22. Silva, T.B.; Menezes, L.R.A.; Sampaio, M.F.C.; Meira, C.S.; Guimarães, E.T.; Soares, M.B.P.; Prata, A.P.N.; Nogueira, P.C.L.; Costa, E.V. Chemical composition and anti-Trypanosoma cruzi activity of essential oils obtained from leaves of Xylopia frutescens and Xylopia laevigata (Annonaceae). Nat. Prod. Commun. 2013, 8, 403–406. [Google Scholar] [CrossRef] [Green Version]
  23. Jürgens, A.; Webber, A.C.; Gottsberger, G. Floral scent compounds of Amazonian Annonaceae species pollinated by small beetles and thrips. Phytochemistry 2000, 55, 551–558. [Google Scholar] [CrossRef]
  24. Maia, J.G.S.; Andrade, E.H.A.; Carreira, L.M.M.; Oliveira, J. Essential oil composition from Duguetia species (annonaceae). J. Essent. Oil Res. 2006, 18, 60–63. [Google Scholar] [CrossRef]
  25. Fechine, I.M.; Navarro, V.R.; Da-Cunha, E.V.L.; Silva, M.S. Alkaloids and volatile constituents from Duguetia flagellaris. Biochem. Syst. Ecol. 2002, 30, 267–269. [Google Scholar] [CrossRef]
  26. Silva, D.B.; Tulli, E.C.O.; Garcez, W.S.; Nascimento, E.A.; Siqueira, J.M. Chemical constituents of the underground stem bark of Duguetia furfuracea (Annonaceae). J. Braz. Chem. Soc. 2007, 18, 1560–1565. [Google Scholar] [CrossRef] [Green Version]
  27. Vidotto, C.; Silva, D.B.; Patussi, R.; Gardini, L.F.; Tibúrcio, J.D.; Alves, S.N.; Siqueira, J.M. Brine shrimp lethality test as a biological model for preliminary selection of pediculicidal components from natural source. Biosci. J. 2013, 29, 255–263. [Google Scholar]
  28. Saldanha, A.A.; Vieira, L.; Ribeiro, R.I.M.A.; Thomé, R.G.; Santos, H.B.; Silva, D.B.; Carollo, C.A.; Oliveira, F.M.; Lopes, D.O.; Siqueira, J.M.; et al. Chemical composition and evaluation of the anti-inflammatory and antinociceptive activities of Duguetia furfuracea essential oil: Effect on edema, leukocyte recruitment, tumor necrosis factor alpha production, iNOS expression, and adenosinergic and opioid. J. Ethnopharmacol. 2019, 231, 325–336. [Google Scholar] [CrossRef]
  29. Valter, J.L.; Alencar, K.M.C.; Sartori, A.L.B.; Nascimento, E.A.; Chang, R.; De Morais, S.A.L.; Laura, V.A.; Yoshida, N.C.; Carollo, C.A.; Da Silva, D.B.; et al. Variação química no óleo essencial das folhas de seis indivíduos de Duguetia furfuracea (Annonaceae). Rev. Bras. Farmacogn. 2008, 18, 373–378. [Google Scholar] [CrossRef] [Green Version]
  30. Almeida, J.R.G.; Facanali, R.; Vieira, M.A.R.; Marques, M.O.M.; Lúcio, A.S.S.C.; Lima, E.O.; Agra, M.F.; Barbosa-Filho, J.M. Composition and antimicrobial activity of the leaf essential oils of Duguetia gardneriana Mart. and Duguetia moricandiana Mart. (Annonaceae). J. Essent. Oil Res. 2010, 22, 275–278. [Google Scholar] [CrossRef]
  31. Rodrigues, A.C.B.C.; Bomfim, L.M.; Neves, S.P.; Menezes, L.R.A.; Dias, R.B.; Soares, M.B.P.; Prata, A.P.N.; Rocha, C.A.G.; Costa, E.V.; Bezerra, D.P. Antitumor Properties of the Essential Oil from the Leaves of Duguetia gardneriana. Planta Med. 2015, 81, 798–803. [Google Scholar] [CrossRef]
  32. Siqueira, J.M.; Müller, L.; Carollo, C.A.; Garcez, W.S.; Boaventura, M.A.D.; Nascimento, E.A. Aromadendrane sesquiterpenoids from the essential oil of leaves of Duguetia glabriuscula—Annonaceae. J. Chil. Chem. Soc. 2003, 48, 89–93. [Google Scholar] [CrossRef]
  33. Sousa, O.V.; Del-Vechio-Vieira, G.; Alves, M.S.; Araújo, A.A.L.; Pinto, M.A.O.; Amaral, M.P.H.; Rodarte, M.P.; Kaplan, M.A. Chemical composition and biological activities of the essential oils from Duguetia lanceolata St. Hil. barks. Molecules 2012, 17, 11056–11066. [Google Scholar] [CrossRef] [Green Version]
  34. Ribeiro, L.P.; Domingues, V.C.; Gonçalves, G.L.P.; Fernandes, J.B.; Glória, E.M.; Vendramim, J.D. Essential oil from Duguetia lanceolata St.-Hil. (Annonaceae): Suppression of spoilers of stored-grain. Food Biosci. 2020, 36, 100653. [Google Scholar] [CrossRef]
  35. Sousa, O.V.; Del-Vechio-Vieira, G.; Santos, B.C.S.; Yamamoto, C.H.; Araújo, A.L.S.M.; Araújo, A.L.A.; Pinto, M.A.O.; Rodarte, M.P.; Alves, M.S. In-vivo and vitro bioactivities of the essential oil of Duguetia lanceolata branches. Afr. J. Pharm. Pharmacol. 2016, 10, 298–310. [Google Scholar]
  36. Bay, M.; Oliveira, J.V.S.; Junior, P.A.S.; Murta, S.M.F.; Santos, A.R.; Bastos, I.S.; Orlandi, P.P.; Junior, P.T.S. In vitro trypanocidal and antibacterial activities of essential oils from four species of the family Annonaceae. Chem. Biodivers. 2019, 16, 11. [Google Scholar] [CrossRef] [PubMed]
  37. Zidorn, C. Plant chemophenetics—A new term for plant chemosystematics/plant chemotaxonomy in the macro-molecular era. Phytochemistry 2019, 163, 147–148. [Google Scholar] [CrossRef] [PubMed]
  38. Fournier, G.; Hadjiakhoondi, A.; Leboeuf, M.; Cavé, A.; Charles, B. Essential oils of Annonaceae. Part VIII. Volatile constituents of the essential oils from three Guatteria species. J. Essent. Oil Res. 1997, 9, 275–278. [Google Scholar] [CrossRef]
  39. Maia, J.G.S.; Andrade, E.H.A.; Carreira, L.M.M.; Oliveira, J.; Araújo, J.S. Essential oil of the Amazon Guatteria and Guatteriopsis species. Flavour Fragr. J. 2005, 20, 478–480. [Google Scholar] [CrossRef]
  40. Maia, J.G.S.; Andrade, E.H.A.; Silva, A.C.M.; Oliveira, J.; Carreira, L.M.M.; Araújo, J.S. Leaf essential oil from four Xylopia species. Flavour Fragr. J. 2005, 20, 474–477. [Google Scholar] [CrossRef]
  41. Dias, D.A.; Urban, S.; Roessner, U. A historical overview of natural products in drug discovery. Metabolites 2012, 2, 303–336. [Google Scholar] [CrossRef] [Green Version]
  42. Kuruppu, A.I.; Paranagama, P.; Goonasekara, C. Medicinal plants commonly used against cancer in traditional medicine formulae in Sri Lanka. Saudi Pharm. J. 2019, 27, 565–573. [Google Scholar] [CrossRef]
  43. Sousa, O.V.; Soares Júnior, D.T.; Del-Vechio, G.; Mattosinhos, R.G.; Gattass, C.R.; Kaplan, M.A.C. Atividades antinociceptiva e antiinflamatória do óleo essencial de cascas de Duguetia lanceolata St. Hil., Annonaceae. Rev. Bras. Farmacogn. 2004, 14, 11–14. [Google Scholar] [CrossRef] [Green Version]
  44. Matos, M.F.C.; Leite, L.I.S.P.; Brustolim, D.; De Siqueira, J.M.; Carollo, C.A.; Hellmann, A.R.; Pereira, N.F.G.; Da Silva, D.B. Antineoplastic activity of selected constituents of Duguetia glabriuscula. Fitoterapia 2006, 77, 227–229. [Google Scholar] [CrossRef]
  45. Mery, B.; Guy, J.B.; Vallard, A.; Espenel, S.; Ardail, D.; Rodriguez-Lafrasse, C.; Rancoule, C.; Magné, N. In vitro cell death determination for drug discovery: A landscape review of real issues. J. Cell Death 2017, 10, 1179670717691251. [Google Scholar] [CrossRef] [Green Version]
  46. Ediriweera, M.K.; Tennekoon, K.H.; Samarakoon, S.R. In vitro assays and techniques utilized in anticancer drug discovery. J. Appl. Toxicol. 2019, 39, 38–71. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Cascaes, M.M.; Carneiro, O.S.; Nascimento, L.D.; de Moraes, A.A.B.; Oliveira, M.S.; Cruz, J.N.; Guilhon, G.M.S.P.; Andrade, E.H.d.A. Essential Oils from Annonaceae Species from Brazil: A Systematic Review of Their Phytochemistry, and Biological Activities. Int. J. Mol. Sci. 2021, 22, 12140. [Google Scholar] [CrossRef] [PubMed]
Biomolecules 12 00615 g001 550
Figure 1. Chemical structures of the main constituents of the essential oils of Duguetia species.
Figure 1. Chemical structures of the main constituents of the essential oils of Duguetia species.
Biomolecules 12 00615 g001
Biomolecules 12 00615 g002 550
Figure 2. Main chemical composition and pharmacological properties of Duguetia species.
Figure 2. Main chemical composition and pharmacological properties of Duguetia species.
Biomolecules 12 00615 g002
Table
Table 1. Medicinal uses of Duguetia species.
Table 1. Medicinal uses of Duguetia species.
SpeciesPopular Name in BrazilPart UsedPopular UsesReferences
D. chrysocarpaPindaíba-da-mataLeaves; branchInflammatory diseases;
gastrointestinal ulcers		[15,16]
D. furfuraceaPinha do campoLeavesRenal colic[17]
RootStomachache[11]
Rheumatism[12]
SeedsAgainst lice[11]
D. flagellarisCaniceiro preto-Rheumatism[13]
D. confinisUnknown-Cough; Toothache[10]
D. staudtiiUnknownBarkGastrointestinal pain;
Breathing difficulties		[6]
D. pycnasteraEnvira pretaBarkMuscle pain[14]
Cough
LeavesFever
Cold sweat
Table
Table 2. Main chemical constituents of Duguetia species EOs.
Table 2. Main chemical constituents of Duguetia species EOs.
Species
(Popular Name in Brazil)		Part UsedTotal ComponentsMajor Constituents 1References
D. asterotricha
(envira, envira-surucucu-da-mata, envireira)		Flowers9 (69.3%)Limonene (14.1%), p-cymene (5.5%), and α-pinene (4.2%)[23]
D. eximia
(unknown)		Leaves and stem76 (4)α-Eudesmol (80.3%) and spathulenol (5.0%)[24]
D. flagellaris
(ameju-preto, caniceiro-preto, pindaíva, pindaíba)		Bark76 (4)Germacrene D (16.5%), cyperene (10.6%), α-muurolol (8.6%), humulene epoxide II (5.3%), spathulenol (5.0%), caryophyllene oxide (5.0%), δ-cadinene (4.3%), α-muurolene (4.2%), and β-elemene (4.0%)[24]
Stem3 (4)Germacrene D (16.5%), cyperene (10.6%) and α-muurolol (8.6%)[25]
Leaves and Stem76 (4)Spathulenol (58.7%), α-muurolol (6.2%) and humulene epoxide II (4.3%)[24]
Branches2 (4)Spathulenol (58.7%), and α-muurolol (6.2%)[25]
D. furfuracea
(araticum, ata brava, pinha do campo, pindaúva do campo, marolinho-do-cerrado, pinha-de-guará)		Stem19 (4)2,4,5-Trimethoxystyrene (29.2%), α-asarone (23.8%), bicyclogermacrene (8.6%), epi-globulol (6.4%), and spathulenol (4.7%)[26]
39 (4)α-Gurjunene (22.2%), 2,4,5-trimethoxystyrene (19.7%), cyperene (16.0%), α-asarone (10.1%), and trans-m-mentha-4,8-diene (6.5%)[27]
24 (4)(E)-Asarone (21.9%), bicyclogermacrene (16.7%), 2,4,5-trimethoxystyrene (16.1%), α-gurjunene (15.0%), cyperene (7.8%), and (E)-caryophyllene (4.6%)[28]
8 (4)α-Asarone (36.4%), 2,4,5-trimethoxystyrene (27.8%), bicyclogermacrene (11.1%), α-gurjunene (10.5%), and cyperene (5.8%)[17]
Leaves 217 (99.4%)β-Phellandrene (42.2%), bicyclogermacrene (20.7%), myrcene (6.8%), spathulenol (5.5%), α-phellandrene (4.6%), and sabinene (4.3%)[29]
17 (99.7%)Sabinene (25.1%), terpinen-4-ol (16.2%), p-cymene (8.3%), caryophyllene oxide (7.7%), and spathulenol (5.1%)
18 (99.2%)Bicyclogermacrene (29.1%), spathulenol (18.3%), germacrene D (9.6%), trans-caryophyllene (9.3%), δ-cadinene (5.5%), and caryophyllene oxide (5.3%)
18 (100%)Bicyclogermacrene (24%), germacrene D (15%), trans-caryophyllene (12.9%), spathulenol (12.4%), and caryophyllene oxide (6.8%)
19 (100%)Bicyclogermacrene (21.4%), germacrene D (13.6%), spathulenol (12.2%), and caryophyllene oxide (5.2%)
20 (99.7%)Terpinen-4-ol (21.6%), spathulenol (20.9%), sabinene (17.3%), and p-cymene (5.6%)
31 (4)Spathulenol (17.8%), bicyclogermacrene (16.2%), germacrene D (13.0%), β-caryophyllene (11.5%), and viridiflorol (4.0%)[27]
D. gardneriana
(jaquinha)		Leaves33 (91.4%)Germacrene D (28.1%), viridiflorene (24.0%), β-pinene (12.6%), α-pinene (9.1%), and β-caryophyllene (5.6%)[30]
4 (96%)β-Bisabolene (81.0%), elemicin (8.0%), and germacrene D (4.2%)[31]
D. glabriuscula
(unknown)		Leaves18 (4)allo-Aromadendrene (22.6%), viridiflorene (13.3%), (–)-ledol (10.6%), α-santaleno (7.5%), (+)-spathulenol (5.8%), allo-aromadendrene-14β-al (5.0%), and farnesyl acetate (4.2%)[32]
Leaves24 (4)allo-Aromadendrene (16.2%), (–)-ledol (13.4%), (+)-spathulenol (12.1%), farnesyl acetate (5.9%), and viridiflorol (4.8%)
D. lanceolata
(araticum-bravo, pinha-brava, embireira, embira, pindaíba, pindaúba, pindaíva)		Bark 372 (99.6%)β-Elemene (12.7%), caryophyllene oxide (12.4%), β-selinene (8.4%), humulene epoxide II (7.4%), and β-eudesmol (6.8%)[33]
51 (99.3%)β-elemene (14.9%), caryophyllene oxide (10.7%) β-selinene (10.4%), β-eudesmol (7.9%), humulene epoxide II (6.8%), β-sinensal (5.4%), and khusinol (5.0%)
Leaves5 (4)β-Bisabolene (56.2%), 2,4,5-trimethoxystyrene (19.1%), trans-muurola-4(14),5-diene (12.2%), and 3,4,5-trimethoxystyrene (8.6%)[34]
Branches37 (92.9%)β-Elemene (8.3%), caryophyllene oxide (7.7%), β-eudesmol (7.2%), β-selinene (7.1%), β-caryophyllene (6.2%), δ-cadinene (5.5%), cadina-1,4-dien-3-ol (5.2%), cadalene (4.8%), and δ-elemene (4.1%)[35]
D. moricandiana
(unknown)		Leaves33 (95.5%)Germacrene D (44.3%), α-pinene (13.0%), viridiflorene (9.3%), β-pinene (9.2%), and β-caryophyllene (6.8%)[30]
D. pycnastera
(ata, envira, envira-preta, envira-surucucu)		Leaves and stem76 (4)Spathulenol (52.2%), allo-aromadendrene (9.1%), germacrene D (7.1%), elemol (5.1%), and bicyclogermacrene (4.8%)[24]
D. quitarensis
(ameju)		Aerial parts20 (97.3%)4-Heptanol (33.8%), α-thujene (18.4%), (E)-caryophyllene (14.4%), germacrene D (6.3%), and α-copaene (5.3%)[36]
D. riparia
(araticu da mata, envira-preta, makahymyra)		Leaves and stem76 (4)Spathulenol (46.5%), caryophyllene oxide (28.9%), and α-pinene (6.1%)[24]
D. trunciflora
(envireira, envira, invira)		Leaves and stem76 (4)α-Pinene (21.1%), bicyclogermacrene (17.6%), bulnesol (10.6%), spathulenol (10.5%), guaiol (8.1%), globulol (5.7%), humulene epoxide II (5.0%), and β-pinene (4.2%)[24]
Bark76 (4)β-Phellandrene (45.7%), guaiol (8.3%), α-cadinol (7.4%), (Z)-β-farnesene (4.8%), 7-epi-sesquithujene (4.5%), and bulnesol (4.2%)
1 Only compounds with percentage concentrations greater than or equal to 4% are displayed. 2 The chemical compositions of the leaves vary due to the intensity of the odor and the location from which they were collected. 3 The extraction times for EO obtention (2 h and 4 h) resulted in different chemical compositions. 4 Percentage not described by the authors in relation to the total composition of the essential oil.
Table
Table 3. Pharmacological properties of Duguetia species EOs.
Table 3. Pharmacological properties of Duguetia species EOs.
Pharmacological EffectsPart UsedActionsReferences
Anti-inflammatory
D. furfuraceaStemAfter 6 h, EO inhibited paw edema induced by LPS by 92.4%.[28]
StemAfter 2 h of LPS injection, doses of 3 and 10 mg/kg of EO inhibited paw edema by 90.9% and 92.42%, respectively. After 4 h, there was a significant reduction effect, with percentages of 77.8% (3 mg/kg) and 81.5% (10 mg/kg).[17]
D. lanceolataBarkEO at doses of 50, 100 and 200 mg/kg significantly reduced paw edema caused by carrageenan in 20.8%, 36.5% and 49.0%, respectively.[43]
BranchesAfter 4 h, EO reduced the formation of paw edema caused by carrageenan by 18.3% (50 mg/kg), 32.3% (100 mg/kg) and 44.1% (200 mg/kg).[35]
Antinociceptive
D. furfuraceaStemEO inhibited formalin-induced activity, and caffeine (10 mg/kg) and naloxone (5 mg/kg) administration reversed the EO’s antinociceptive activity.[28]
StemInhibition of 43.4% and 44.1% of formalin-induced activity was observed during the 1st phase at doses of 10 and 30 mg/kg, respectively. In the 2nd phase, there was also reduction in licking time at doses of 10 mg/kg (30.9%) and 30 mg/kg (39.8%).[17]
D. lanceolataBarkNumber of abdominal contractions (ED50 = 21.8 mg/kg) and paw-licking time 1st phase (ED50 = 5.3 mg/kg) and 2nd phase (ED50 = 1.4 mg/kg) were reduced in the formalin test.[43]
BranchesIn the formalin test, EO caused significant and time-dependent inhibition of paw licking at doses of 50, 100 and 200 mg/kg at 1st and 2nd phases.[35]
Antibacterial and Antifungal
D. gardnerianaLeavesEO showed weak activity against Staphylococcus aureus and Candida guilliermondii.[30]
D. lanceolataBarkEO inhibited the growth of Staphylococcus pyogenes, Escherichia coli and Candida albicans with MIC values ranging from 20 to 125 µg/mL.[33]
D. moricandianaLeavesEO was active against Staphylococcus aureus and Candida albicans[30]
D. quitarensisAerial partsEO was active for Gram-positive microorganisms Streptococcus mutans and Streptococcus pyogenes with MIC of 37.5 µg/mL.[37]
Trypanocidal
D. quitarensisAerial partsEO showed trypanocidal activity against the amastigote and trypomastigote forms of Trypanosoma cruzi with IC50 values of 0.26 and 0.54 µg/mL, respectively.[36]
Antioxidant
D. lanceolataBranchesEO presented antioxidant effect, demonstrated through the DPPH radical, potency reduction and β-carotene assays. It inhibited lipid peroxidation by 41.5% (EC50 equal to 159.4 µg/mL).[35]
Cytotoxic and Antitumor
D. furfuraceaStemEO was active against A. salina with LC50 values of 2.6 µg/mL.[26]
StemEO was active against A. salina with LC50 of 715.2 mg/cm3.[27]
D. lanceolataBarkEO was cytotoxic against A. salina with LC50 of 49.0 and 60.7 µg/mL, corresponding to different times of extraction.[36]
D. gabriusculaLeavesEO exhibited cytotoxicity towards tumor cell lines and showed IC50 value of 11.6 µg/mL for human larynx carcinoma (Hep2) cell line.[44]
LeavesEO was toxic to A. salina with LC50 of 1.6 mg/mL.[32]
D. gardnerianaLeavesEO exhibited cytotoxic effect with IC50 values of 16.9, 19.2, 13.1 and 19.3 µg/mL against B16-F10, HepG2, HL-60 and K562 cell lines, respectively. In the in vivo experiment, tumor growth was reduced by 5.4 and 37.5% at doses of 40 and 80 mg/kg, respectively.[31]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Santos, A.C.d.; Nogueira, M.L.; Oliveira, F.P.d.; Costa, E.V.; Bezerra, D.P. Essential Oils of Duguetia Species A. St. Hill (Annonaceae): Chemical Diversity and Pharmacological Potential. Biomolecules 2022, 12, 615. https://doi.org/10.3390/biom12050615

AMA Style

Santos ACd, Nogueira ML, Oliveira FPd, Costa EV, Bezerra DP. Essential Oils of Duguetia Species A. St. Hill (Annonaceae): Chemical Diversity and Pharmacological Potential. Biomolecules. 2022; 12(5):615. https://doi.org/10.3390/biom12050615

Chicago/Turabian Style

Santos, Albert C. dos, Mateus L. Nogueira, Felipe P. de Oliveira, Emmanoel V. Costa, and Daniel P. Bezerra. 2022. "Essential Oils of Duguetia Species A. St. Hill (Annonaceae): Chemical Diversity and Pharmacological Potential" Biomolecules 12, no. 5: 615. https://doi.org/10.3390/biom12050615

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop